Seven Fleet Capital Management LP — 13F Holdings & Portfolio
CIK 2092021 · latest 13F-HR filed 2026-06-04
Seven Fleet Capital Management LP manages $318.3M in 13F-reported U.S. long-equity assets across 115 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are CGON (30.61%), TNGX (3.30%), RVMD (2.47%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 1 new position, exited 0, added to 0, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$318.3M
Long-equity book
115
Distinct positions
2026-03-31
Filed 2026-06-04
+1 / −0 / ↑0 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 156944101 | $97.4M | 30.61% | 1,439,393 | SH |
| 2 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $10.5M | 3.30% | 502,012 | SH |
| 3 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $7.9M | 2.47% | 80,792 | SH |
| 4 | TYRA BIOSCIENCES INC | TYRA | 90240B106 | $7.5M | 2.35% | 195,685 | SH |
| 5 | LIQUIDIA CORPORATION | LQDA | 53635D202 | $7.1M | 2.23% | 187,876 | SH |
| 6 | AGIOS PHARMACEUTICALS INC | AGIO | 00847X104 | $7.1M | 2.23% | 209,547 | SH |
| 7 | CENTURY THERAPEUTICS INC | IPSC | 15673T100 | $6.7M | 2.09% | 2,947,826 | SH |
| 8 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $6.4M | 2.02% | 164,030 | SH |
| 9 | VAXCYTE INC | PCVX | 92243G108 | $6.3M | 1.98% | 108,450 | SH |
| 10 | TANGO THERAPEUTICS INC | TNGX | 87583X110 | $6.3M | 1.98% | 300,648 | SH |
| 11 | COGENT BIOSCIENCES INC | COGT | 19240Q201 | $5.8M | 1.81% | 149,399 | SH |
| 12 | AVALO THERAPEUTICS INC | AVTX | 05338F307 | $5.4M | 1.69% | 360,064 | SH |
| 13 | MINERVA NEUROSCIENCES INC | NERV | 603380206 | $5.4M | 1.68% | 889,254 | SH |
| 14 | CG ONCOLOGY INC | CGON | 156944100 | $5.1M | 1.61% | 75,758 | SH |
| 15 | PHARVARIS N V | PHVS | N69605108 | $4.9M | 1.53% | 172,731 | SH |
| 16 | ABIVAX SA | ABVX | 00370M103 | $4.8M | 1.51% | 43,052 | SH |
| 17 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $4.6M | 1.43% | 54,258 | SH |
| 18 | PHARVARIS N V | PHVS | N69605109 | $4.1M | 1.28% | 143,966 | SH |
| 19 | CYTOKINETICS INC | CYTK | 23282W605 | $4.0M | 1.27% | 61,269 | SH |
| 20 | SOLENO THERAPEUTICS INC | SLNO | 834203309 | $3.9M | 1.22% | 115,770 | SH |
| 21 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E103 | $3.7M | 1.17% | 95,253 | SH |
| 22 | ERASCA INC | ERAS | 29479A108 | $3.6M | 1.13% | 222,468 | SH |
| 23 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $3.6M | 1.12% | 128,168 | SH |
| 24 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F106 | $3.4M | 1.05% | 714,000 | SH |
| 25 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $3.2M | 1.00% | 213,819 | SH |
| 26 | CENTURY THERAPEUTICS INC | IPSC | 15673T101 | $3.2M | 0.99% | 1,400,000 | SH |
| 27 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 29842P105 | $3.1M | 0.99% | 433,515 | SH |
| 28 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $2.9M | 0.90% | 86,283 | SH |
| 29 | TAYSHA GENE THERAPIES INC | TSHA | 877619106 | $2.8M | 0.88% | 625,708 | SH |
| 30 | ASCENDIS PHARMA A/S | ASND | 04351P101 | $2.8M | 0.88% | 12,179 | SH |
| 31 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $2.7M | 0.86% | 516,972 | SH |
| 32 | DAMORA THERAPEUTICS INC | DMRA | 36322Q206 | $2.6M | 0.82% | 101,248 | SH |
| 33 | KALVISTA PHARMACEUTICALS INC | KALV | 483497103 | $2.6M | 0.81% | 128,487 | SH |
| 34 | RELAY THERAPEUTICS INC | RLAY | 75943R102 | $2.6M | 0.81% | 257,738 | SH |
| 35 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $2.4M | 0.75% | 14,055 | SH |
| 36 | COMPASS THERAPEUTICS INC | CMPX | 20454B105 | $2.2M | 0.70% | 423,566 | SH |
| 37 | DIANTHUS THERAPEUTICS INC | DNTH | 252828109 | $2.2M | 0.70% | 26,551 | SH |
| 38 | EUPRAXIA PHARMACEUTICALS INC | EPRX | 29842P106 | $2.0M | 0.63% | 276,000 | SH |
| 39 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $1.9M | 0.59% | 99,887 | SH |
| 40 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $1.9M | 0.59% | 69,571 | SH |
| 41 | SOLENO THERAPEUTICS INC | SLNO | 834203310 | $1.8M | 0.57% | 54,000 | SH |
| 42 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $1.8M | 0.56% | 3,393 | SH |
| 43 | CYTOMX THERAPEUTICS INC. | CTMX | 23284F105 | $1.7M | 0.55% | 371,398 | SH |
| 44 | LEONABIO INC | LONA | 04746L203 | $1.7M | 0.53% | 164,676 | SH |
| 45 | SAVARA INC | SVRA | 805111101 | $1.6M | 0.51% | 295,688 | SH |
| 46 | PERSPECTIVE THERAPEUTICS INC | CATX | 46489V302 | $1.6M | 0.50% | 379,082 | SH |
| 47 | ASSEMBLY BIOSCIENCES INC | ASMB | 045396207 | $1.6M | 0.49% | 56,147 | SH |
| 48 | SAB BIOTHERAPEUTICS INC | SABS | 78397T203 | $1.5M | 0.48% | 400,000 | SH |
| 49 | MINERVA NEUROSCIENCES INC | NERV | 603380205 | $1.5M | 0.47% | 248,476 | SH |
| 50 | ZAI LAB LTD | ZLAB | 98887Q104 | $1.5M | 0.46% | 77,858 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-06-04 | $318.3M | 115 | 0001013594-26-000652 |
| 2026-03-31 | 2026-05-15 | $315.1M | 114 | 0001013594-26-000616 |
| 2025-12-31 | 2026-04-02 | $147.8M | 87 | 0001013594-26-000420 |
| 2025-12-31 | 2026-02-26 | $131.5M | 87 | 0001013594-26-000305 |